The fatty acid oxidation pathway as a therapeutic target for insulin resistance

Author： Clapham John C   Storlien Leonard H  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.10, Iss.5, 2006-10, pp. : 749-757

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac Aging and Insulin Resistance: Could Insulin/Insulin-Like Growth Factor (IGF) Signaling be used as a Therapeutic Target?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5684-5694

Bentham Science Publishers

Access to resources Recommend Favorite

The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome

By Simão Andréa Name Colado   Lozovoy Marcell Alysson Batisti   Dichi Isaias  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1175-1187

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic approaches to insulin resistance

By Laight D.W.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1703-1709

Informa Healthcare

Access to resources Recommend Favorite

Role of Insulin in the Pathogenesis of Free Fatty Acid-Induced Insulin Resistance in Skeletal Muscle

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 65-74

Bentham Science Publishers

Access to resources Recommend Favorite

The JNK pathway as a therapeutic target for diabetes

By Kaneto Hideaki  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 581-592

Informa Healthcare

Access to resources Recommend Favorite